Bridging study to launch after coming Oct.

The revised bill of "Regulation pertaining to Drug Safety and Efficacy Evaluation" looks delayed in its implementation probably after the coming Oct. The regulation replaces the current clinical phase III study requirement for a new drug registration by so-called bridging study in an attempt to remove international diplomatic dispute on trade and promote a new drug development.

The KFDA fin...